NCT04195100View on ClinicalTrials.gov

Local Pilocarpine for Relieving Dry Mouth

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 1, 2019

Study Completion Date

January 31, 2020

Conditions
Patients of Advanced Age (≥ 70 Years) With a Clinical Diagnosis of Chronic Dry Mouth
Interventions
DRUG

Pilocarpine Ophthalmic Solution

"1. low dose pilocarpine = 3 x 2.0 mg = 3 x 2 drops of pilocarpine 20.0 mg/ml (2%) per day~2. high dose pilocarpine = 3 x 5.0 mg = 3 x 5 drops of pilocarpine 20.0 mg/ml (2%) per day"

Trial Locations (1)

6202 AZ Maastricht

Maastricht University Medical Centre, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT04195100 - Local Pilocarpine for Relieving Dry Mouth | Biotech Hunter | Biotech Hunter